1 | 2-deoxy-2 [F-18] fluoro-2-d-glucose | [2] D-glucose D-glucose, Dextrose, unspecified form (75gm Glucose Tolerance Drink) | [1] Glucose
Glucose
💬
| - | - | [1] 49 49 💬
|
2 | 5% glucose water solution | [2] Dextrose, unspecified form Dextrose, unspecified form (75gm Glucose Tolerance Drink), Water | [1] Water
Water
💬
| - | - | [1] 2 2 💬
|
3 | [18F]Fluoro-2-deoxy-2-D-glucose | [2] D-glucose D-glucose, Dextrose, unspecified form (75gm Glucose Tolerance Drink) | [1] Glucose
Glucose
💬
| - | - | [2] 86 86, 88 💬
|
4 | D-glucose | [2] D-glucose D-glucose, Dextrose, unspecified form (75gm Glucose Tolerance Drink) | [1] Glucose
Glucose
💬
| - | - | [3] 49 49, 86, 88 💬
|
5 | Glucose | [2] D-glucose D-glucose, Dextrose, unspecified form (75gm Glucose Tolerance Drink) | [1] Glucose
Glucose
💬
| - | - | [12] 2 2, 6, 13, 49, 50, 66, 86, 88, 96, 97, 257, 299 💬
|
6 | Glucose intake | [1] Dextrose, unspecified form Dextrose, unspecified form (75gm Glucose Tolerance Drink) | - | - | - | [1] 257 257 💬
|
7 | Glucose Tablet | [1] Dextrose, unspecified form Dextrose, unspecified form (75gm Glucose Tolerance Drink) | - | - | - | [1] 50 50 💬
|
8 | Modified Oral Glucose Tolerance Test (50g 4-hours) | [1] Dextrose, unspecified form Dextrose, unspecified form (75gm Glucose Tolerance Drink) | - | - | - | [1] 299 299 💬
|
9 | Oral Glucose Tolerance test (75g 2-hour) | [1] Dextrose, unspecified form Dextrose, unspecified form (75gm Glucose Tolerance Drink) | - | - | - | [1] 299 299 💬
|
10 | Renin Angiotensin system (RAS) blockade or Inhibitors of sodium glucose transporter 2 (SGLT2i) | [2] Angiotensin II Angiotensin II, Dextrose, unspecified form (75gm Glucose Tolerance Drink) | [2] Angiotensin II
Angiotensin II
,
Angiotensin II
💬
| [2] AGTR1 AGTR1, AGTR2 💬
| [16] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 66 66 💬
|
11 | Sodium tanshinone IIA sulfonate diluted with 5% glucose solution,20mg sildenafil citrate by mouth | [2] Dextrose, unspecified form Dextrose, unspecified form (75gm Glucose Tolerance Drink), Sildenafil | [1] Sildenafil
Sildenafil
💬
| [1] PDE5A PDE5A 💬
| [3] Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬
|